共 50 条
Efavirenz as a potential drug for the treatment of triple-negative breast cancers
被引:0
|作者:
P.-T. Chiou
S. Ohms
P. G. Board
J. E. Dahlstrom
D. Rangasamy
M. G. Casarotto
机构:
[1] The Australian National University,ACRF Department of Cancer Biology and Therapeutics, The John Curtin School of Medical Research
[2] The Australian National University,The John Curtin School of Medical Research
[3] The Australian National University,Anatomical Pathology, ACT Pathology, Canberra Hospital and ANU Medical School, ANU College of Health and Medicine
来源:
Clinical and Translational Oncology
|
2021年
/
23卷
关键词:
Triple-negative breast cancer;
Efavirenz;
LINE-1;
Retrotransposon;
Fatty acid metabolism;
D O I:
暂无
中图分类号:
学科分类号:
摘要:
引用
收藏
页码:353 / 363
页数:10
相关论文